Plasminogen activator inhibitor type-1 (PAI-1) levels are decreased in NIDDM patients treated with insulin

Clinical and Applied Thrombosis/Hemostasis

Volumn 4, Issue 2, 1998, Pages 138-139

  Galajda, Peter ^a   Martinka, Emil ^a   Staško, Ján ^a   Mokáň, Marian ^a   Kubisz, Peter ^a  

^a Martinska Fakultna Nemocnica   (Slovakia)

Author keywords

Insulin treatment; Non insulin dependent diabetes mellitus; PAI 1

Indexed keywords

C PEPTIDE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SULFONYLUREA; THROMBOCYTE FACTOR 4; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM INJURY; FEMALE; HEMOSTASIS; HUMAN; INSULIN TREATMENT; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031957692     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969800400212     Document Type: Article

References (10)

1. Alessi MC, Juhan-Vague I, Kooistra T, et al. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by hepatocellular cell line HepG2. Thromb Haemost 1988;60:491.
2. Hamsten A, Eriksson P. Fibrinolysis and atherosclerosis: an update. Fibrinolysis 1994;8:253.
3. Juhan-Vague I, Alessi MC, Vague P. Increased plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991;34:457.
4. Vague P, Juhan-Vague I, Aillaud MF, et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 1986;35:250.
5. Wiman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb Haemost 1995;74:71.
6. Jokl R, Lazarchick J, Johnston PS, Colmell JA. Postprandial activation of fibrinolysis with type 2 diabetes mellitus. Abstracts of 15th International Diabetes Federation Congres. Kobe, 1994:301.
7. Mehrabian M, Peter JB, Barnard RJ, et al. Dietary regulation of fibrinolytic factors. Atherosclerosis 1990;84:25.
8. Marckmann P. Diet, blood coagulation and fibrinolysis. Dan Med Bull 1995;42:410.
9. Kubo K, Takashina S. Relationship between plasma insulin and plasminogen activator inhibitor-1 in non insulin dependent diabetic patients. Abstracts of 15th International Diabetes Federation Congres. Kobe, 1994:380.
10. Lindstrom T, Olsson AG, Vonschenck H, et al. Insulin treatment improves microalbuminuria and other cardiovascular risk factors in patients with type 2 diabetes mellitus. J Int Med 1994;235:253.